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Jocelyne R Benatar1,2* and Ralph AH Stewart1Abstract
Background: Dairy food is an important natural source of saturated and trans fatty acids in the human diet. This
study evaluates the effect of dietary advice to change dairy food intake on plasma fatty acid levels known to be
present in milk in healthy volunteers.
Methods: Twenty one samples of whole fat dairy milk were analyzed for fatty acids levels. Changes in levels of
plasma phospholipid levels were evaluated in 180 healthy volunteers randomized to increase, not change or reduce
dairy intake for one month. Fatty acids were measured by gas chromatography–mass spectrometry and levels are
normalized to d-4 alanine.
Results: The long chain fatty acids palmitic (13.4%), stearic (16.7%) and myristic (18.9%) acid were most common
saturated fats in milk. Four trans fatty acids constituted 3.7% of the total milk fat content. Increased dairy food
intake by 3.0 (± 1.2) serves/ day for 1 month was associated with small increases in plasma levels of myristic (+0.05,
95% confidence level-0.08 to 0.13, p = 0.07), pentadecanoic (+0.014, 95% confidence level −0.016 to 0.048, p = 0.02)
and margaric acid (+0.02, −0.03 to 0.05, p = 0.03). There was no significant change in plasma levels of 4 saturated, 4
trans and 10 unsaturated fatty acids. Decreasing dairy food intake by 2.5 (± 1.2) serves per day was not associated
with change in levels of any plasma fatty acid levels.
Conclusion: Dietary advice to change dairy food has a minor effect on plasma fatty acid levels.
Trial registration: ACTRN12612000574842.
Keywords: Trans fatty acids, Saturated fatty acids, Dairy food, Vaccenic acid, Palmitelaidic acid, Randomized
controlled studyBackground
A healthy diet is important to reduce the risk of cardiovas-
cular disease [1] and diabetes [2]. In observational studies,
high intake of saturated [3] and trans fatty acids [4] and
low intake of polyunsaturated fats [5] is associated with
increased cardiovascular risk. Studies also suggest that
increased plasma levels of trans [6] and saturated [7] fatty
acids are associated with increased risk of cardiovascular
disease. Plasma levels of trans, odd-numbered saturated
and polyunsaturated (n-3 and n-6) fatty acids reflect* Correspondence: jbenatar@adhb.govt.nz
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article, unless otherwise stated.dietary intake as these are not endogenously synthesized
[8]. The aim of dietary advice to reduce intake of foods
with saturated fats and TFA is to reduce plasma levels of
‘harmful’ fats and increase levels of ‘beneficial’ polyunsat-
urated fats.
Dairy food is a highly complex food comprised of con-
stituents thought to be both harmful and beneficial for
cardiovascular health. It is the most abundant source of
animal fat in the diet including saturated fats and ‘natur-
ally occurring’ ruminant trans fatty acids (rTFA) [8]. It is
rich in in long chain saturated fatty acids such as myr-
istic and palmitic acids; thought to be harmful for car-
diovascular health [9]. However, dairy food also contains
unsaturated, short and medium chain saturated fatty
acids thought to be beneficial for heart health [10,11].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ful, the effects of trans fatty acids from dairy on cardio-
vascular health is less clear [12]. Some studies suggest
rTFA may be beneficial to health [13] but others suggest
a neutral effect [14,15]. These assumptions are based on
the premise that certain trans fatty acids, like vaccenic
acid, are exclusively from dairy [16], and others like elai-
dic acid are exclusively industrial [17].
This inconsistent data on the health effects of dairy
[18-20] has led to confusing messages for consumers.
Cardiovascular guidelines recommend avoidance of dairy
fat [18,21] but others recommend at least 3–4 servings
of dairy food per day [19].
No randomized studies have assessed the effects of
changing dairy food intake in the real world on rTFA, sat-
urated and polyunsaturated fatty acid levels. Consumers
change intake of whole food rather than a specific fat. This
study is designed to see whether changes in whole food re-
sult in significant changes in fatty acid levels. In this study,
we analyzed the composition of fatty acid in dairy food in
New Zealand. We then evaluated the effects of dietary
advice to increase, decrease or not change daily dairy food
intake for one month on plasma fatty acid levels in a
randomized clinical trial with180 healthy volunteers.
Methods
Randomized study
A more detailed description of the randomized study , and
effects of dietary intervention on cardio-metabolic risk
factors have been reported previously [20]. Healthy volun-
teers (n = 180) living in Auckland, New Zealand regularly
consuming dairy and who were willing to modify dairy in-
take for one month were recruited by advertisement from
February 2011 to September 2011. Exclusion criteria in-
cluded inability to tolerate dairy food, known diabetes,
cardiovascular disease, inflammatory conditions, currently
taking any lipid or glucose modifying medication and
age ≤18 years. Ethics approval was obtained from the
Northern X Ethics Committee and all participants
provided written informed consent.
Participants were instructed to fast for 10 hours prior to
clinic visits. Blood samples were collected in ethylene-
diamine-tetra acetic acid tubes on all participants at baseline
and after one month. Plasma was separated in a 4°Celsius
centrifuge within 20 minutes of the blood draw and stored
at −80°Celsius in nunc tubes until analysis.
Participants were randomized by a computer generated
randomization algorithm to one of three possible arms; in-
creased dairy (n = 60), reduced dairy (n = 60) or no change
(n = 60) for 1 month. Participants were given advice on
how to change dairy intake including written diet sheets.
Participants randomized to increased dairy were asked to
increase intake of full fat dairy food by more than three
servings a day. Those asked to reduce dairy food wereasked to eliminate dairy food and red meat as much as
possible from the diet. This was to ensure that participants
did not increase uptake of alternative sources of ruminant
trans fatty acids. A follow-up assessment was arranged for
one month. The National Cancer Institute Diet History
Questionnaire [22], a validated food frequency question-
naire, was used to assess all dairy and red meat intake
during the preceding 3 days at baseline and 1 month.
Milk samples
Seven brands of whole (3.3% fat) cow’s milk were pur-
chased in April 2011. These included homogenised, non-
homogenised, organic and non-organic brands. Three
samples of each brand were collected (total n = 21), dec-
anted into nunc tubes and stored at −800 Celsius until
analysis. Fasting blood samples were taken in ethylene-
diamine-tetra acetic acid tubes. Plasma was separated and
stored at −70°Celsius until analysis.
Analysis of milk and plasma
Phospholipids analysis of milk and plasma was performed
at the School of Biological Science, Auckland University.
Total lipids were extracted with AR Methanol and fatty
acid methyl esters formed by transmethylation. Fatty com-
position was assessed by gas chromatography–mass spec-
trometry (Hewlett Packard 6890 Gas Chromatograph with
an SGE BPX70 column and a Flame Ionisation Detector.
Peaks were normalised to d4-analine.
The coefficient of variation for each fatty acids at this
laboratory is added to Table 1.
Definitions
The United States Department of Agriculture criteria
[23] were used to define serving size. For example one
serving size was equivalent to 250 ml 3% milk, 250 ml
yogurt, 500 ml 1.5% milk or 1/3 cup cheddar cheese.
The total dairy fat content ingested in g/day was calcu-
lated based on the reported intakes of each food, and
the fat content from manufacturers’ labels [24].
Saturated fatty acids were defined as short chain
(aliphatic tails of2 < 6 carbons), medium chain (aliphatic
tails of 6–12 carbons), long chain (aliphatic tails of 13–
21 carbons), and very long chain (aliphatic tails of >21
carbons) [25].
Statistical analysis
Baseline and one month visit levels of fatty acids and
change in these measurements between baseline and one
month were summarized as median and interquartile range.
A 30% difference in vaccenic acid levels was expected to be
seen with the intervention. Sixty in each group was esti-
mated to give 80% power to detect a treatment difference
with a two-sided 0.05 significance level, if the true
difference in between the treatments is 1.5.
Table 1 Fatty acids in milk and in human plasma at baseline
Levels in whole








Fumaric acid (C4:1n2t) 0.059 (0.004) 0.071 ND ND
Palmitelaidic acid(C16:1n7t) 0.007 (0.009) 1.292 0.022 (0.031) 1.593
Vaccenic acid (C18:1n7t) 0.334 (0.183) 0.551 0.458 (0.210) 0.465
Myristelaidic acid (C17:1n9t) 0.041 (0.006) 0.153 0.073 (0.313) 4.012
Saturated fats
Caprylic acid (C8:0) 0.791 (0.213) 0.265 0.005 (0.003) 0.583
Capric acid (C10:0) 1.293 (0.347) 0.248 0.015 (0.019) 1.44
Lauric acid (C12:0) 1.520 (0.474) 0.322 0.034 (0.054) 1.633
Tridecylic acid (C13:0) 0.018 (0.003) 0.136 ND ND
Myristic acid (C14:0) 1.996 (0.345) 0.179 0.262 (0.131) 0.476
Pentadecanoic acid (C15:0) 0.167 (0.088) 0.532 0.084 (0.032) 0.374
Palmitic acid (C16:0) 1.767 (0.265) 0.153 2.221 (0.635) 0.301
Margaric acid (C17:0) 0.122 (0.014) 0.824 0.160 (0.077) 0.534
Stearic acid (C18:0) 1.415 (0.137) 0.099 1.966 (0.548) 0.336
Arachidic acid (C20:0) 0.016 (0.002) 0.133 0.013 (0.004) 3.587
Lignoceric acid (C23:0) 0.006 (0.001) 0.224 ND ND
Polyunsaturated fats
Eicosatetraenoic acid (C20:4n8c,11c,14c,17c) 0.018 (0.003) 0.142 0.231 (0.868) 0.73
Linoleic acid (C18:2n9c,12c) 0.160 (0.012) 0.615 0.789 (0.373) 0.564
gamma-Linolenic acid (C18:3n6c,9c,12c) 0.176 (0.038) 0.222 0.076 (0.097) 1.230
Eicosadienoic acid (C20:2n11c,14c) 0.002 (0.002) 0.412 0.041 (0.017) 0.489
Arachidonic acid (C20:4n5c,8c,11c,14c) 0.020 (0.006) 0.285 0.556 (0.146) 0.283
Cervonic acid (C22:6n4c,7c,10c,13c,16c,19c) 0.024 (0.004) 0.283 0.381(0.132) 0.374
Monounsaturated fats
Myristoleic acid (C14:1n9c) 0.12 (0.04) 0.33 ND ND
Palmitoleic acid (C16:1n9)* 0.106 (0.026) 0.18 0.081(0.055) 0.53
Oleic acid (C18:1n9c)* 0.898 (0.085) 0.10 0.69(0.21) 0.32
Gondoic acid (C20:1n11c)* 0.004 (0.004) 0.78 ND ND
Units are levels normalized to d4- alanine. Results are mean (standard deviation). The coefficient of variation for each plasma fatty acid is also listed.
ND = not detected.
*Monounsaturated fatty acids.
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pleted the study, as no measurable outcomes were avail-
able on those who did not return at one month. Baseline
characteristics and scores were compared across the three
arms using the analysis of variance (ANOVA). Analysis of
covariance (ANCOVA) was used to determine if there
were significant differences in fatty acid values between
the three dairy groups [26]. ANCOVA was conducted on
the follow up values adjusting for the baselines values. For
the few variables that did not meet the ANCOVA assump-
tions [27], ANOVA was used to determine significant
differences in follow-up values between the three dairy
groups. Secondary analysis was performed to determine
differences within randomized groups using ANOVA.Statistical analyses were performed with SAS software
version 9.3 (SAS Institute, Cary, NC).
To adjust for multiplicity testing the Bonferroni method
was used [28].
Ethics approval
NTX/10/11/15 (Northern X ethics committee, Auckland,
New Zealand).
Results
Fatty acids in milk
3.3% whole fat milk contained 90% saturated fats, 3.7%
TFA and 5.3% unsaturated fats (Table 1). The most com-


































































































































































































































































































































Figure 1 Fatty acids found in New Zealand milk. Plasma fatty acids are measured by mass spectrometry and normalized to d-4 alanine.
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http://www.nutritionj.com/content/13/1/3212.3 (SD 4.7)%, and long chain palmitic acid 14.3 (SD
5.8)% and myristic acid 16.1 (SD 3.5)%. Vaccenic acid
was the most plentiful rTFA (2.8% of milk fat), and oleic
acid is the most common unsaturated fat (Figure 1).
Randomized study
176 of 180 randomized participants completed the study.




Age (years) 48.6 (12.0)
Heart rate (Beats per minute) 63.7 (8.2)
Systolic blood pressure 116.6 (12)
Diastolic blood pressure 70.3 (9)
Waist circumference (cm) 84.2 (12.3)
Hip circumference(cm) 100.1 (8.8)
BMI 24.2 (4.0)
TC (mmol/L) 5.31 (0.97)
HDL (mmol/L) 1.70 (0.42)
LDL (mmol/L) 3.12 (0.88)
TG (mmol/L) 1.12 (0.81)
Insulin resistance (HOMA) 1.38 (0.82)
Results are mean (standard deviation) and P > 0.03 for all.age of the population was 47 (IQR: 38–55) years and 70%
of the participants were female. The average body mass
index was 24.5 (SD 4.0) and participants were normoten-
sive with an average blood pressure (BP) 110/70 (SD10/8)
mmHg. There were no significant differences in baseline
characteristics by dietary group.
Change in dairy food intake assessed by the FFQ
across all three groups was significant (p < 0.001). Forup
Same dairy intake Increased dairy intake
60 60
66 63
45.3 (12.4) 46.3 (10.5)
63.0 (9.1) 64.1 (8.6)
114.2 (10) 113.9 (11)
70.0 (8) 70.2 (8)
83.2 (12.6) 84.3 (9.8)
100.8 (10.1) 101.7 (7.1)
24.8 (4.0) 24.6 (4.1)
5.13 (0.98) 5.15 (0.93)
1.68 (0.47) 1.68 (0.48)
2.97 (0.86) 2.98 (0.78)
1.12 (0.72) 1.04 (0.64)
1.43 (1.08) 1.47 (1.1)
Table 3 The difference across the three dairy groups using ANCOVA













Baseline 0.50 0.51 0.51
(0.32 to 0.63) (0.36 to 0.61) (0.37 to 0.61)
1 month 0.54 0.49 0.50
(0.40 to 0.64) (0.36 to 0.60) (0.36 to 0.68)
Change 0.05 −0.03 −0.04 0.74 0.24 0.31
(−0.14 to 0.16) (−0.23 to 0.26) (−0.22 to 0.30)
Myristelaidic acid
Baseline 0.018 0.018 0.018
(0.015 to 0.024) (0.013 to 0.023) (0.015 to 0.023)
1 month 0.019 0.018 0.018
(0.015 to 0.024) (0.015 to 0.023) (0.015 to 0.023)
Change 0.001 0.001 0.001 0.79 0.91 0.26
(−0.003 to 0.005) (−0.004 to 0.005) (−0.004 to 0.005)
Saturated Fatty Acid
Myristic acid
Baseline 0.22 0.24 0.25
(0.17 to 0.30) (0.18 to 0.32) (0.19 to 0.33)
1 month 0.25 0.24 0.29
(0.19 to 0.33) (0.203 to 0.32) (0.22 to 0.36)
Change 0.01 0.01 0.05 0.39 1.00 0.07
(−0.05 to 0.1) (−0.08 to 0.09) (−0.08 to 0.13)
Palmitic Acid
Baseline 2.33 2.32 2.20
(1.88 to 2.75) (1.97 to 2.70) (1.96 to 2.64)
1 month 2.43 2.34 2.51
(2.09 to 2.89) (1.97 to 2.91) (2.06 to 2.93)
Change −0.52 0.42 1.37 0.79 0.47 0.42
(−0.51 to 0.90) (−0.47 to 0.62) (−0.41 to 9.37)
Stearic acid
Baseline 1.98 1.98 1.97
(1.77 to 2.21) (1.84 to 2.15) (1.76 to 2.24)
1 month 2.12 2.15 2.12
(1.88 to 2.35) (1.91to 2.39) (1.83 to 2.4)
Change +0.05 +0.17 +0.13 0.84 0.56 0.41
(−0.27 to 0.48) (−0.10 to 0.52) (−0.32 to 0.56)
Pentadecanoic acid
Baseline 0.084 0.084 0.085
(0.072 to 0.101) (0.076 to 0.120) (0.070 to 0.101)
1 month 0.079 0.085 0.098
(0.054 to 0.088) (0.068 to 0.104) (0.078 to 0.120)
Change −0.006 −0.00 +0.014 0.11 0.33 0.02
(−0.015 to 0.00) (−0.015 to 0.017) (−0.016 to 0.048)
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Table 3 The difference across the three dairy groups using ANCOVA (Continued)
Margaric acid
Baseline 0.17 0.17 0.16
( 0.12 to 0.22) ( 0.12 to 0.21) ( 0.09 to 0.21)
1 month 0.15 0.17 0.18
( 0.08 to 0.19) ( 0.08 to 0.18) (0.14 to 0.24)
Change −0.02 −0.001 +0.02 0.95 0.54 0.03
( −0.09 to 0.03) ( −0.08 to 0.02) (−0.03 to 0.05)
ANCOVA was used unless assumptions were not met. ANOVA was used for all others (Table 4) Fatty acids are standardized to d4- alanine and presented as
median (interquartile range).
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day, p < 0.001, no change was −0.6 (0.2) serves/day, p =
0.78 and for decreased dairy diet −2.5 (1.2) serves/day,
p < 0.001. The total difference between those asked to
increased and reduced dairy food intake was 5.5 (SD1.4)
serves per day, p < 0.001. Change in dairy fat for the
reduced dairy diet was −10.4 (10.1) g/day, no change
was −3.4 (7.9) g/day, and increased dairy was +12.5
(15.7) g/day, p < 0.001. There was no significant change
in intake of food from ruminant sources such as meat or
goat milk and cheese by randomized group.
The effect of changing dairy food intake on plasma
fatty acid levels is displayed in Tables 3 and 4. There was
no significant change in TFA between randomized
groups. In those randomized to decrease dairy food in-
take, there was no significant change in fatty acid levels
compared to the control group. In those randomized to
increase dairy food intake, plasma levels of pentadeca-
noic (p = 0.02) and margaric acid (p = 0.03) increased
compared to the control group. When comparison was
made between increased and decreased dairy food in-
take (Figure 2), there was an increase in caprylic, myristic,
pentadecanoic and margaric acid. Other long chain and
medium chain saturated fats did not change significantly.
After adjustment for multiple testing, change in pentade-
canoic acid levels between increased and reduced dairy
intake remained significant (p = 0.02). However, change in
other fatty acid levels was no longer significant.
There was no significant change in total saturated fats
for increased dairy diet +13.1 (95% confidence interval
(CI) -1.2 to + 25.3)%, same dairy diet +2.4 (95% CI −9.2
to +11.3)% or decreased dairy diet +3.5 (95% CI −5.5
to +11.6)%. The FFQ indicated that participants random-
ized to reduce dairy food intake switched to rice, almond
and soy milk products.
Change within randomized groups was then analyzed.
There was no significant change in total rTFA for in-
creased dairy diet −5.5% (95% CI −15.4 to +10.2 )%, same
dairy diet −9.1(95% CI -20 to +1.2)%, and decreased dairy
diet +10.1 (95% CI −2.4 to +22.5)%. Levels of the individual
trans fatty acid isomers, vaccenic acid, palmitelaidic acid
and myristelaidic acid also did not change. Pentadecanoic(15:0), myristic (14:0) and margaric (heptadecanoic (17:0))
acid increased with increased dairy intake (p = 0.02 and
0.03 respectively); however, there was no significant change
for reduced dairy intake.
Figure 3 shows associations between levels of milk
fatty acids and effects of increasing dairy food intake on
plasma levels of fatty acids. Figure 4 shows associations
between levels of milk fatty acids and effects of redu-
cing dairy food intake on plasma levels of fatty acids.
Change in plasma levels of fatty acid isomers did not
correlate with the amount of that fatty acid in dairy
food. For example, myristic acid and palmitic acid were
the most plentiful saturated fats in milk, but changing
dairy food intake did not correlate with change in
plasma levels.
Discussion
Dairy food is the richest natural source of ‘harmful’ fats
like long chain saturated and trans fatty acid in the diet
[29]. Changing dietary intake should significantly affect
plasma levels of these fats, especially long chain fatty
acids, and rTFA thought to be almost exclusively from
dairy food. In this study cow’s milk was analyzed to as-
sess fatty acids present in dairy food. Fatty acid compos-
ition in milk is mainly dependent on the feed and
seasonality [30] and varies between countries. It was
therefore essential to confirm fatty acids levels concur-
rent with the randomized study to allow for interpret-
ation of study findings. Milk was considered the most
useful dairy food to analyze as participants increased
dairy food intake mainly by increasing intake of whole
fat milk, yogurt and ice cream rather than cheese.
Intake of dairy food significantly changed for all those
randomized to increase and decrease dairy food intake,
with those that increased dairy food consuming on aver-
age 5.5 serves per day more than those that decreased
dairy food intake. However, whilst there was a small in-
crease in plasma levels of myristic, pentadecanoic acid
and margaric acid with increased dairy consumption,
plasma levels of most fatty acids present in milk did not
change with diet. After multiplicity testing, only penta-
decanoic acid changed significantly.
Trans fatty acids
Saturated fatty acids
Poly unsaturated fatty acids
Mon unsaturated fatty acids 
Plasma levels fatty acids
Decreased dairy intake Increased dairy intake
Figure 2 Change in plasma levels of fatty acids with a high dairy compared to a low dairy food diet. Results are expressed as a standard
mean difference. This graph shows that increasing dairy food intake compared to the control group (no change) relatively increases plasma levels
of caprylic, myristic, pentadecanoic and margaric acid, but has no effect on other fatty acids. However when correcting for multiplicity testing;
only the change in pentadecanoic acid remained significantly different between high and low dairy diets.
Table 4 The difference across the three dairy groups using ANOVA for those fats who did not meet the assumptions
for ANCOVA
Trans fatty acid Reduced dairy intake Same dairy intake Increased dairy intake P value
Palmitelaidic acid
Baseline 0.033 0.04 0.02
(0.00 to 0.45) (0.00 to 0.43) (0.00 to 0.32)
1 month 0.049 0.039 0.034
(0.00 to 0.50) (0.00 to 0.49) (0.01 to 0.39)
Change 0.00 0.00 0.00 0.96
(−0.09 to 0.09) (−0.27 to 0.22) (−0.07 to 0.14)
Linoelaidic acid
Baseline 0.000 0.000 0.000
(0.000 to 0.0296) (0.000 to 0.026) (0.001 to 0.018)
1 month 0.000 0.000 0.000
(0.000 to 0.0233) (0.000 to 0.0274) (0.000 to 0.033)
Change 0.000 0.000 0.000 0.53
(−0.010 to 0.000) (−0.014 to 0.016) (0.000 to 0.018)
Saturated fats
Lauric acid
Baseline 0.025 0.026 0.025
(0.000 to 0.039) (0.000 to 0.043) (0.000 to 0.042)
1 month 0.030 0.026 0.036
(0.000 to 0.056) (0.000 to 0.041) (0.025 to 0.052)
Change 0.00 0.000 0.012 0.12
(−0.011 to 0.027) (−0.022 to 0.024) (−0.005 to 0.024)
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Figure 3 Correlation between fatty acid levels in milk and change in plasma fatty acid levels in those participants asked to increase
dairy food intake. Results are mean levels and are normalized to d4 alanine.
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http://www.nutritionj.com/content/13/1/32Dietary guidelines recommend consumption of low fat
dairy food to reduce intake of long chain fatty acids like
myristic and palmitic acid that are associated with in-
creased cardiovascular risk [31], and stearic acid that is
associated with reduced HDL cholesterol [32]. However
the effects of pentadecanoic acid, which increased in
those asked to increase dairy food intake, are not known.
Some studies have suggested that margaric acid and
pentadecanoic acid are markers of dairy food intake
[33], however this study suggests that in the real world,
large changes in dairy food intake marginally changes
fatty acids. Moreover, reducing dairy food intake had noFigure 4 Correlation between fatty acid levels in milk and change in
dairy food intake. Results are mean levels and are normalized to d4 alanineffect on plasma levels of these fats suggesting that these
may be present in other food sources. Participants in-
creased uptake of food that are good sources of satu-
rated fats such as foods with palm and coconut oils
(such as table spreads, processed foods) and almond
milk. Ultimately, separating the health effects of these
fatty acids is difficult to justify when giving dietary ad-
vice, as they are highly correlated because they are found
in the same food (e.g., beef and dairy products).
Similarly, rTFA did not change significantly between
groups. Dietary advice to reduce dairy food intake in
patients with cardiovascular disease is not aimed atplasma fatty acid levels in those participants asked to decrease
e.
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thought to be too low to have biological effects [34] and
some studies suggest that vaccenic acid may not be
harmful for human health [13]. Previous studies have
identified palmitelaidic acid as exclusively from dairy
food [35,36]; however, this study suggests that these
assumptions may be misplaced.
It is possible in persons who decreased dairy food, rTFA
from other sources increased. Oils containing precursors
to vaccenic and palmitelaidic acid are increasingly used
for processing and cooking food. Increased heat or pres-
sure during cooking can increase rTFA levels in these oils
[37]. Vaccenic acid is found in dairy free processed foods
such as takeaway chips in the United Kingdom [38]. Dairy
is also added to products like margarines, often assumed
to be dairy- free. When these are heated, TFA levels can
significantly be increased [37]. A less likely possibility is
that humans are able to catalyze a reaction to convert
small amounts of cis to TFA. Whilst humans are able to
convert vaccenic acid to conjugated linoleic acid by delta-
9 desaturase in the liver [39,40], bioconversion of cis to
trans fatty acids has not been demonstrated.
Changing dairy food intake for one month could be too
short to affect plasma TFA levels. However, in feeding
studies changes in plasma TFA occur within 2–3 weeks
[41,42], and other dairy fatty acids like pentadecanoic and
margaric acid [33], changed with a change in dairy intake
within 3 weeks. There was a large difference in dairy food
intake within and between groups. In contrast to some
observational studies [35,36], no correlation was observed
between vaccenic acid and palmitelaidic acid either at
baseline or 1 month (r = 0.053 and 0.089 respectively)
suggesting they are not exclusively from the same source.
Limitations
It is possible participants did not adhere to the random-
ized diet. However, food frequency questionnaires sug-
gested good adherence and that consumption of other
sources of TFA such as processed food, and goat’s milk
or meat were not increased.
Food frequency questionnaires may not accurately re-
flect dietary intake [43,44]. Studies comparing food fre-
quency measures with repeated dietary recalls generally
show correlations of the order of 0.4–0.7 [45].
Conclusion
Dietary advice to change the intake of dairy food does
not significantly change plasma fatty acid levels includ-
ing ruminant trans fatty acids. Dietary advice may need
to focus on total food patterns rather than individual
food groups to affect plasma fatty acid levels.
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